Trials / Completed
CompletedNCT00102830
Study Evaluating AMG 386 in Adult Patients With Advanced Solid Tumors
A Phase 1 Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of AMG 386 in Adult Patients With Advanced Solid Tumors
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Amgen · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to test the safety, tolerability and pharmacokinetic (PK) profile of AMG 386 after intravenous administration in adult subjects with advanced solid tumors.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AMG 386 |
Timeline
- First posted
- 2005-02-04
- Last updated
- 2010-08-20
Source: ClinicalTrials.gov record NCT00102830. Inclusion in this directory is not an endorsement.